Ten-year follow-up of a province-wide cohort of surgical lung cancer patients in Nova Scotia

Canadian Journal of Surgery

Volumn 51, Issue 4, 2008, Pages 257-262

  Wong, Daniel R ^a   Henteleff, Harry J ^a  

^a QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 49449084091     PISSN: 0008428X     EISSN: 14882310     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Ellison LF, Gibbons L; Canadian Cancer Survival Analysis Group. Five-year relative survival from prostate, breast, colorectal and lung cancer. Health Rep 2001;13:23-34.
2. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710-7.
3. Williams DE, Pairolero PC, Davis CS, et al. Survival of patients surgically treated for stage I lung cancer. J Thorac Cardiovasc Surg 1981;82:70-6.
4. Schulze S, Holm-Bentzen M, Høier-Madsen K, et al. Results of surgical treatment for lung cancer. Scand J Thorac Cardiovasc Surg 1983;17:61-4.
5. Mery CM, Pappas AN, Bueno R, et al. Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. Chest 2005;128:237-45.
6. Martini N, Bains MS, Burt ME, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995;109:120-9.
7. Ginsberg RJ, Rubinstein LU; Lung Cancer Study Group. Randomized trial of lobectomy versus limited resection for T1N0M0 non-small-cell lung cancer. Ann Thorac Surg 1995;60:615-23.
8. Warren WH, Faber LP. Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma. Five-year survival and patterns of intrathoracic recurrence. J Thorac Cardiovasc Surg 1994;107:1087-93.
9. Martini N, Rusch VW, Bains MS, et al. Factors influencing ten-year survival in resected stages I to IIIa non-small cell lung cancer. J Thorac Cardiovasc Surg 1999;117:32-6.
10. Winton T, Livingston R, Johnson D, et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 2005;352:2589-97.
11. Arriagada R, Bergman B, Dunant A, et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004;350:351-60.
12. Strauss GM, Herndon J, Maddaus MA, et al. Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB non-small cell lung cancer (NSCLC): report of Cancer and Leukemia Group B (CALGB) protocol 9633 [abstract 7019]. J Clin Oncol 2004;22:621s.
13. Douillard J, Rosell R, Delena M, et al. (OBS) in completely resected (stage I-III) non-small-cell lung cancer (NSCLC) patients (PTS): final results after 70-month median follow-up [abstract 7013]. J Clin Oncol 2005;23:624s.
14. Bollen EC, van Duin CJ, Theunissen PH, et al. Mediastinal lymph node dissection in resected lung cancer: morbidity and accuracy of staging. Ann Thorac Surg 1993;55:961-6.
15. Izbicki JR, Passlick B, Karg O, et al. Impact of radical systematic mediastinal lymphadenectomy on tumor staging in lung cancer. Ann Thorac Surg 1995;59:209-14.
16. Sawyer TE, Bonner JA, Gould PM, et al. Factors predicting patterns of recurrence after resection of N1 non-small cell lung cancer. Ann Thorac Surg 1999;68:1171-6.
17. Sugarbaker DJ. Lung cancer: the case for limited surgical resection in non-small cell lung cancer. Thorax 2003;58:639-41.
18. International Early Lung Cancer Action Program Investigators; Henschke CI, Yankelevitz DF, Libby DM, et al. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006;355:1763-71.